Skip to main content

Peer Review reports

From: A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine

Original Submission
10 Jan 2019 Submitted Original manuscript
5 Feb 2019 Author responded Author comments - Nigel Fleeman
Resubmission - Version 2
5 Feb 2019 Submitted Manuscript version 2
10 Apr 2019 Reviewed Reviewer Report - Barbara Jarzab
21 Apr 2019 Reviewed Reviewer Report - Maomei Ruan
26 Aug 2019 Reviewed Reviewer Report - Reviewer 2
18 Oct 2019 Author responded Author comments - Nigel Fleeman
Resubmission - Version 3
18 Oct 2019 Submitted Manuscript version 3
23 Oct 2019 Reviewed Reviewer Report - Reviewer 2
14 Nov 2019 Author responded Author comments - Nigel Fleeman
Resubmission - Version 4
14 Nov 2019 Submitted Manuscript version 4
Publishing
18 Nov 2019 Editorially accepted
12 Dec 2019 Article published 10.1186/s12885-019-6369-7

You can find further information about peer review here.

Back to article page